78 related articles for article (PubMed ID: 27399349)
1. Impaired Follistatin Secretion in Cirrhosis.
Rinnov AR; Plomgaard P; Pedersen BK; Gluud LL
J Clin Endocrinol Metab; 2016 Sep; 101(9):3395-400. PubMed ID: 27399349
[TBL] [Abstract][Full Text] [Related]
2. Exercise-Induced Secretion of FGF21 and Follistatin Are Blocked by Pancreatic Clamp and Impaired in Type 2 Diabetes.
Hansen JS; Pedersen BK; Xu G; Lehmann R; Weigert C; Plomgaard P
J Clin Endocrinol Metab; 2016 Jul; 101(7):2816-25. PubMed ID: 27163358
[TBL] [Abstract][Full Text] [Related]
3. Circulating Follistatin Is Liver-Derived and Regulated by the Glucagon-to-Insulin Ratio.
Hansen JS; Rutti S; Arous C; Clemmesen JO; Secher NH; Drescher A; Gonelle-Gispert C; Halban PA; Pedersen BK; Weigert C; Bouzakri K; Plomgaard P
J Clin Endocrinol Metab; 2016 Feb; 101(2):550-60. PubMed ID: 26652766
[TBL] [Abstract][Full Text] [Related]
4. [Effects of somatostatin and glucagon on secretion of bile lipids in man].
Nakamura T; Imamura K; Machida K; Tando I; Takebe K
Klin Med (Mosk); 1996; 74(9):23-6. PubMed ID: 9121081
[No Abstract] [Full Text] [Related]
5. The role of octreotide on renal function in patients with advanced cirrhosis.
Fierbinţeanu-Braticevici C; Udeanu M; Usvat R; Andronescu D
Rom J Intern Med; 2004; 42(1):173-81. PubMed ID: 15529607
[TBL] [Abstract][Full Text] [Related]
6. Regulation of urea synthesis by diet protein and carbohydrate in normal man and in patients with cirrhosis. Relationship to glucagon and insulin.
Hamberg O
Dan Med Bull; 1997 Jun; 44(3):225-41. PubMed ID: 9233544
[TBL] [Abstract][Full Text] [Related]
7. Nadolol reduces insulin sensitivity in liver cirrhosis: a randomized double-blind crossover trial.
Lee WG; Murphy R; McCall JL; Gane EJ; Soop M; Tura A; Plank LD
Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 27667324
[TBL] [Abstract][Full Text] [Related]
8. Effects of glucose on hepatic conversion of aminonitrogen to urea in patients with cirrhosis: relationship to glucagon.
Hamberg O; Vilstrup H
Hepatology; 1994 Jan; 19(1):45-54. PubMed ID: 7903954
[TBL] [Abstract][Full Text] [Related]
9. Effect of somatostatin on liver blood flow and liver metabolic activity in patients with cirrhosis.
Merkel C; Gatta A; Caregaro L; Sacerdoti D; Rondana M; Ruol A
Scand J Clin Lab Invest; 1987 Nov; 47(7):667-72. PubMed ID: 2891182
[TBL] [Abstract][Full Text] [Related]
10. Myostatin and its association with abdominal obesity, androgen and follistatin levels in women with polycystic ovary syndrome.
Chen MJ; Han DS; Yang JH; Yang YS; Ho HN; Yang WS
Hum Reprod; 2012 Aug; 27(8):2476-83. PubMed ID: 22693174
[TBL] [Abstract][Full Text] [Related]
11. Evidence for an augmented glucagon dependence of hepatic glucose production in cirrhosis of the liver.
Keller U; Sonnenberg GE; Burckhardt D; Perruchoud A
J Clin Endocrinol Metab; 1982 May; 54(5):961-8. PubMed ID: 6120952
[TBL] [Abstract][Full Text] [Related]
12. Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis.
Patella S; Phillips DJ; Tchongue J; de Kretser DM; Sievert W
Am J Physiol Gastrointest Liver Physiol; 2006 Jan; 290(1):G137-44. PubMed ID: 16123203
[TBL] [Abstract][Full Text] [Related]
13. Influence of gastrointestinal factors on glucose metabolism in patients with cirrhosis.
Junker AE; Gluud LL; Holst JJ; Knop FK; Vilsbøll T
J Gastroenterol Hepatol; 2015 Oct; 30(10):1522-8. PubMed ID: 25867498
[TBL] [Abstract][Full Text] [Related]
14. Prandial regulation of ghrelin secretion in humans: does glucagon contribute to the preprandial increase in circulating ghrelin?
Soule S; Pemberton C; Hunt P; Cole D; Raudsepp S; Inder W
Clin Endocrinol (Oxf); 2005 Oct; 63(4):412-7. PubMed ID: 16181233
[TBL] [Abstract][Full Text] [Related]
15. Effects of terlipressin and somatostatin on liver and thorax blood volumes in patients with cirrhosis.
Kalambokis G; Tsiouris S; Tsianos EV; Baltayiannis G; Pakou B; Fotopoulos A
Liver Int; 2010 Oct; 30(9):1371-8. PubMed ID: 20738780
[TBL] [Abstract][Full Text] [Related]
16. [Effect of somatostatin on splanchnic hemodynamics in liver cirrhosis].
Merkel C; Gatta A; Zuin R; Finucci GF; Arnaboldi L; Ruol A
Minerva Med; 1984 Nov; 75(44):2673-8. PubMed ID: 6151151
[TBL] [Abstract][Full Text] [Related]
17. Unresponsiveness of hepatic nitrogen metabolism to glucagon infusion in patients with cirrhosis: dependence on liver cell failure.
Fabbri A; Marchesini G; Bianchi G; Bugianesi E; Bortoluzzi L; Zoli M; Pisi E
Hepatology; 1993 Jul; 18(1):28-35. PubMed ID: 8325618
[TBL] [Abstract][Full Text] [Related]
18. Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis.
Kalambokis G; Economou M; Paraskevi K; Konstantinos P; Pappas C; Katsaraki A; Tsianos EV
J Gastroenterol Hepatol; 2005 Jul; 20(7):1075-81. PubMed ID: 15955217
[TBL] [Abstract][Full Text] [Related]
19. Circulating follistatin in relation to energy metabolism.
Hansen JS; Plomgaard P
Mol Cell Endocrinol; 2016 Sep; 433():87-93. PubMed ID: 27264073
[TBL] [Abstract][Full Text] [Related]
20. Role of gluconeogenesis from amino acids in determining fasting and absorptive levels of plasma ammonia in cirrhosis.
Trevisani F; Bernardi M; Grilli F; De Palma R; Piazzi S; Patrono D; Gasbarrini G
Am J Gastroenterol; 1988 Jun; 83(6):646-51. PubMed ID: 2897785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
